Skip to main navigation Skip to search Skip to main content

Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence

Michal Harel, Rona Ortenberg, Siva Karthik Varanasi, Kailash Chandra Mangalhara, Mariya Mardamshina, Ettai Markovits, Erez N Baruch, Victoria Tripple, May Arama-Chayoth, Eyal Greenberg, Anjana Shenoy, Ruveyda Ayasun, Naama Knafo, Shihao Xu, Liat Anafi, Gali Yanovich-Arad, Georgina D Barnabas, Shira Ashkenazi, Michal J Besser, Jacob SchachterMarcus Bosenberg, Gerald S Shadel, Iris Barshack, Susan M Kaech, Gal Markel, Tamar Geiger

Research output: Contribution to journalArticlepeer-review

Abstract

Proteomic profiling of melanomas from patients undergoing immunotherapy reveals key mediators of tumor immunogenicity.

Original languageEnglish
Pages (from-to)236-250.e18
JournalCell
Volume179
Issue number1
DOIs
StatePublished - 19 Sep 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • anti-PD-1
  • cancer metabolism
  • immune checkpoint inhibitors
  • immunotherapy
  • lipid metabolism
  • mass spectrometry
  • melanoma
  • mitochondrial metabolism
  • proteomics
  • tumor-infiltrating lymphocytes

All Science Journal Classification (ASJC) codes

  • General Biochemistry,Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence'. Together they form a unique fingerprint.

Cite this